About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Beijing Hospital Atherosclerosis Study | Clinical Trials | Clareo Health

Back to clinical trial search

UNKNOWNNCT03072797

Beijing Hospital Atherosclerosis Study

The Beijing Hospital Atherosclerosis Study (BHAS) is a prospective, single-center, observational cohort study performed at the Beijing Hospital in Beijing, China. Subjects enrolled in this study will ...

Lead sponsor: Beijing Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Ruiyue Yang, M.D.

CONTACT

+861058115049 [email protected]

Wenduo Zhang, M.D.

CONTACT

+861085136232 [email protected]

Sponsors

Lead Sponsor

Beijing Hospital

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Age \>18y
•Consent for the study
•Primary reason for catheterization is concern for ischemic heart disease
•Complete clinical and coronary angiogram data available

Exclusion Criteria

•Primary pulmonary hypertension or severe lung disease
•Cardiac transplantation
•Other solid organ transplant
•Peripheral vascular intervention only
•Right heart catheterization only
•Advanced heart failure
•Congenital heart disease
•Women who are pregnant or nursing, or preparing for pregnant during the study period
•Progressive fatal disease
•History of alcoholism or drug abuse
•Patients with mental illness and are being treated
•Patients are undergoing radiotherapy or chemotherapy
•Acute and chronic infectious diseases

Related studies

Health Ahead Comparative Effectiveness Study

NCT07669168 · Health Services Accessibility, Rural Health, and more

Real-life Registry in Patients With Coronary Artery Disease Treated With the SELUTION Sirolimus-eluting Balloon. Selution Iberia Registry

NCT07256249 · Cardiovascular Diseases

Effect of Mobile-Based Home Cardiac Rehabilitation on Coronary Plaque

NCT07660419 · Coronary Artery Disease (CAD), Coronary Stenosis

RECRUITINGPhase 3

A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk

NCT07613294 · Atherosclerosis, Cardiovascular Diseases, and more

Using Indoor Air Filtration to Slow Atherothrombosis Progression in Adults With Ischemic Heart Disease History

NCT05867381 · Air Pollution, Atherosclerosis

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 27, 2022Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment3,000

Start dateMar 2017

Last updatedApr 27, 2022

Condition

Atherosclerosis Cardiovascular Diseases Coronary Artery Disease Myocardial Ischemia Stroke

Locations shown

Bejing Hosptial

Beijing, Beijing Municipality

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 27, 2022Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions